Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123960684 | 12396068 | 4 | F | 20160511 | 20160712 | 20160524 | 20160930 | EXP | CR-ROCHE-1761250 | ROCHE | 52.64 | YR | F | Y | 0.00000 | 20160930 | MD | CR | CR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123960684 | 12396068 | 1 | PS | Omalizumab | OMALIZUMAB | 1 | Subcutaneous | 300 MG, QMO | 103976 | 300 | MG | SOLUTION FOR INJECTION | /month | ||||||
| 123960684 | 12396068 | 2 | C | IRBESARTAN. | IRBESARTAN | 1 | Unknown | 150 MG, BID (LONG TERM THERAPY) | U | 0 | 150 | MG | BID | ||||||
| 123960684 | 12396068 | 3 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG, QD (LONG TERM THERAPY) | U | 0 | 25 | MG | QD | ||||||
| 123960684 | 12396068 | 4 | C | LOVASTATINE | LOVASTATIN | 1 | Unknown | 40 MG, QD (LONG TERM THERAPY) | U | 0 | 40 | MG | QD | ||||||
| 123960684 | 12396068 | 5 | C | BECLOMETASONE | BECLOMETHASONE DIPROPIONATE | 1 | Unknown | 500 UG, 4 TIMES/DAY (LONG TERM THERAPY) | U | 0 | 500 | UG | QID | ||||||
| 123960684 | 12396068 | 6 | C | FORMOTEROL | FORMOTEROL | 1 | Unknown | 9 UG, BID (LONG TERM THERAPY) | U | 0 | 9 | UG | BID | ||||||
| 123960684 | 12396068 | 7 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Unknown | 10 MG, (LONG TERM THERAPY) | U | 0 | 10 | MG | |||||||
| 123960684 | 12396068 | 8 | C | ALBUTEROL. | ALBUTEROL | 1 | Unknown | 200 MCC, PRN (LONG TERM THERAPY) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123960684 | 12396068 | 1 | Asthma |
| 123960684 | 12396068 | 2 | Hypertension |
| 123960684 | 12396068 | 3 | Hypertension |
| 123960684 | 12396068 | 4 | Hypercholesterolaemia |
| 123960684 | 12396068 | 5 | Asthma |
| 123960684 | 12396068 | 6 | Asthma |
| 123960684 | 12396068 | 7 | Asthma |
| 123960684 | 12396068 | 8 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123960684 | 12396068 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123960684 | 12396068 | Cyanosis | |
| 123960684 | 12396068 | Extrasystoles | |
| 123960684 | 12396068 | Oedema | |
| 123960684 | 12396068 | Pain in extremity | |
| 123960684 | 12396068 | Peripheral ischaemia | |
| 123960684 | 12396068 | Rheumatic disorder | |
| 123960684 | 12396068 | Ventricular arrhythmia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123960684 | 12396068 | 1 | 20150922 | 0 |